Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2014-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm500455pPMID 25023617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications

  2014cited by this paper
• Alkali Metal Thioselenophosphinates, M[SeSPR2]: One‐Pot Multicomponent Synthesis, DFT Study, and Synthetic Application

  2013cited by this paper
• The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway.

  2013cited by this paper
• Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.

  2013cited by this paper
• Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies.

  2013cited by this paper
• Organoruthenium antagonists of human A₃ adenosine receptors.

  2013cited by this paper
• Synthesis of Ferrocenyl and Ruthenocenyl Thioamide Derivatives Using a Single-Step Three-Component Reaction

  2013cited by this paper
• Metal–Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation

  2013cited by this paper
• Solution equilibrium studies on anticancer ruthenium(II)-η6- p-cymene complexes of 3-hydroxy-2(1H)-pyridones

  2013cited by this paper
• Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation.

  2012cited by this paper
• Evidence-based approach to assess passive diffusion and carrier-mediated drug transport.

  2012cited by this paper
• Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity.

  2012cited by this paper
• Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B.

  2012cited by this paper
• Preparation of new half sandwich ruthenium arene complexes with aminophosphines as potential chemotherapeutics.

  2012cited by this paper
• Challenges and Opportunities in the Development of Organometallic Anticancer Drugs

  2012cited by this paper
• Organometallic ruthenium(II) arene compounds with antiangiogenic activity.

  2011cited by this paper
• Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.

  2011cited by this paper
• Organometallic ruthenium-based antitumor compounds with novel modes of action

  2011cited by this paper
• Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity.

  2010cited by this paper
• In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

  2010cited by this paper
• Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry.

  2010cited by this paper
• Targeting proteins with metal complexes.

  2009cited by this paper
• KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

  2008cited by this paper
• p53: a guide to apoptosis.

  2008cited by this paper
• Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry.

  2008cited by this paper
• The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways

  2008cited by this paper
• Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

  2008cited by this paper
• 16. (η6‐Hexamethylbenzene)Ruthenium Complexes

  2007cited by this paper
• Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis

  2007cited by this paper
• Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Organic cation transporters are determinants of oxaliplatin cytotoxicity.

  2006cited by this paper
• Solid-phase synthesis of peptide-platinum complexes using platinum-chelating building blocks derived from amino acids

  2005cited by this paper
• Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175

  2005cited by this paper
• Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.

  2005cited by this paper
• Charting biologically relevant chemical space: a structural classification of natural products (SCONP).

  2005cited by this paper
• Chemical space and biology

  2004cited by this paper
• A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

  2004cited by this paper
• Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan

  2004cited by this paper
• Navigating chemical space for biology and medicine

  2004cited by this paper
• Automated parallel solid-phase synthesis and anticancer screening of a library of peptide-tethered platinum(II) complexes.

  2003cited by this paper
• The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide.

  2003cited by this paper
• Plasma membrane phospholipid asymmetry.

  2002cited by this paper
• In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

  2002cited by this paper
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002cited by this paper
• Combinatorial and Evolution-Based Methods in the Creation of Enantioselective Catalysts.

  2001cited by this paper
• [Ru(η6-p-cymene)Cl2(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo- [3.3.1.1]decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells

  2001cited by this paper
• Non-platinum chemotherapeutic metallopharmaceuticals.

  1999cited by this paper
• Combinatorial libraries of transition-metal complexes, catalysts and materials.

  1998cited by this paper
• The properties of known drugs. 1. Molecular frameworks.

  1996cited by this paper
• Preparation and x-ray crystal structure analysis of the hydroxo-bridged, dinuclear (.pi.-arene)ruthenium(II) cation in [Ru2(.eta.6-C6H6)2(.mu.-OH)3]Cl.3H2O

  1988cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

  1987cited by this paper
• η4-Bonding in (arene)ruthenium complexes of octamethylnaphthalene

  1984cited by this paper
• Benzene Complexes of Ruthenium(II)

  1972cited by this paper

• Insights into the cytotoxicity of photoactivatable Ru(II) carbonyl complexes towards human liver carcinoma cells.

  2025cites this paper
• Bi-anthracene based ruthenium and iridium metalla-rectangles: Coordination driven self-assembly and anti-cancer activities

  2025cites this paper
• Identification of novel triazolylquinoxaline-based metal complexes supported by experimental and virtual screenings.

  2025cites this paper
• Roll of Biologically Active Chitosan as a Schiff Base: A Review

  2025cites this paper
• Synthesis and Single-Crystal X-ray Structures of Sterically Hindered Three Half-Sandwich (η6-p-Cymene)ruthenium(II) Schiff Base Complexes: Catalytic Applications in Selective Monoalkylation of Amines and Synthesis of Amides

  2025cites this paper
• Enhanced Anticancer Activity of Novel Bi (III)‐Thiosemicarbazone Complexes Against Lung Cancer

  2025cites this paper
• Structural and biomedical investigations of novel ruthenium schiff base complexes

  2025cites this paper
• Discovery of Phototoxic Metal Complexes with Antibacterial Properties via a Combinatorial Approach

  2025cites this paper
• Recent advances on the DNA interaction properties of Schiff bases and their metal complexes

  2024cites this paper
• Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer.

  2024cites this paper
• A semi-automated, high-throughput approach for the synthesis and identification of highly photo-cytotoxic iridium complexes.

  2024cites this paper
• Discovery of antibacterial manganese(i) tricarbonyl complexes through combinatorial chemistry

  2024cites this paper
• An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as Anticancer Agents: A Review.

  2024cites this paper
• A bis-quinoline ruthenium(II) arene complex with submicromolar cytotoxicity in castration-resistant prostate cancer cells.

  2024cites this paper
• Anticancer behaviour of 2,2'-(pyridin-2-ylmethylene)bis(5,5-dimethylcyclohexane-1,3-dione)-based palladium(II) complex and its DNA, BSA binding propensity and DFT study.

  2024cites this paper
• High-Throughput Combinatorial Metal Complex Synthesis.

  2024cites this paper
• Combinatorial Synthesis toward the Discovery of Highly Cytotoxic Fe(III) Complexes.

  2024cites this paper
• Copper and Manganese Complexes of Pyridinecarboxaldimine Induce Oxidative Cell Death in Cancer Cells.

  2024cites this paper
• Synthesis, characterization, and investigation of catalytic properties of RuII complexes with Schiff bases based on 2-hydroxybenzaldehyde and 5-bromo-2-hydroxybenzaldehyde

  2024cites this paper
• Synthetic route for O,S‐coordinated organotin (IV) aldehydes: Spectroscopic, computational, XRD, and antibacterial studies

  2024cites this paper
• Dual Antimicrobial-Anticancer Potential, Hydrolysis, and DNA/BSA Binding Affinity of a Novel Water-Soluble Ruthenium-Arene Ethylenediamine Schiff base (RAES) Organometallic.

  2024cites this paper
• Oxidovanadium(IV) Salicylidene Glycine Complex with Phenanthroline as Co-ligand: Synthesis, Characterization, and Catalytic Degradation of Methyl Orange with H_2O_2

  2024cites this paper
• Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.

  2023cites this paper
• Using Machine Learning to Predict the Antibacterial Activity of Ruthenium Complexes.

  2023cites this paper
• Ruthenium arene complexes with chalcone ligands incorporating pyridyl and anthryl units: Synthesis, aqueous stability and interaction with quadruplex DNA

  2023cites this paper
• Harnessing Transition Metal Scaffolds for Targeted Antibacterial Therapy.

  2023cites this paper
• 3-acetyl-coumarin-substituted thiosemicarbazones and their ruthenium, rhodium and iridium metal complexes: An investigation of the antibacterial, antioxidant and cytotoxicity activities

  2023cites this paper
• Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses.

  2023cites this paper
• Potent saccharinate-containing palladium(II) complexes for sensitization to cancer therapy.

  2023cites this paper
• Targeting Pathogenic Formate-Dependent Bacteria with a Bioinspired Metallo-Nitroreductase Complex.

  2023cites this paper
• Electrospray Mass Spectrometry to Study Combinatorial iClick Reactions and Multiplexed Kinetics of [Ru(N3)(N∧N)(terpy)]PF6 with Alkynes of Different Steric and Electronic Demand.

  2023cites this paper
• Schiff base complexes, cancer cell lines, and anticancer evaluation: a review

  2022cites this paper
• Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

  2022cites this paper
• Various coordination behavior of coumarin appended Schiff bases towards Ruthenium(II) ion: synthesis, spectral characterization and biological evaluation

  2022cites this paper
• Targeting of the intracellular redox balance by metal complexes towards anticancer therapy

  2022cites this paper
• Recent Progress in Metal‐Incorporated Acyclic Schiff‐Base Derivatives: Biological Aspects

  2022cites this paper
• A Ru(II)-arene-ferrocene complex with promising antibacterial activity.

  2022cites this paper
• Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes.

  2022cites this paper
• Targeting translation: a promising strategy for anticancer metallodrugs

  2021cites this paper
• Bypassing the Resistance Mechanisms of the Tumor Ecosystem by Targeting the Endoplasmic Reticulum Stress Pathway Using Ruthenium- and Osmium-Based Organometallic Compounds: An Exciting Long-Term Collaboration with Dr. Michel Pfeffer

  2021cites this paper
• Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment

  2021cites this paper
• Synthesis, antimicrobial and antiproliferative activities of new self-assembly benzimidazole-bridged aren ruthenium rectangles in human breast cancer cells

  2021cites this paper
• Synthesis, spectroscopic/electrochemical characterization, DNA/Protein binding studies and bioactivity assays of Ru(II) carbonyl complexes of 4-oxo-4H-chromene-3-carbaldehyde thiosemicarbazones

  2021cites this paper
• Schiff-base silver nanocomplexes formation on natural biopolymer coated mesoporous silica contributed to the improved curative effect on infectious microbes

  2021cites this paper
• Rational approaches towards inorganic and organometallic antibacterials

  2021cites this paper
• The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties.

  2021cites this paper
• A new palladium(II) phosphino complex with ONS donor Schiff base ligand: Synthesis, characterization and catalytic activity towards Suzuki-Miyaura cross-coupling reaction

  2021cites this paper
• Recent Advances in Schiff Base Ruthenium Metal Complexes: Synthesis and Applications

  2021cites this paper
• Synthesis, characterization, DNA binding, antibacterial, antidiabetic, molecular docking and DFT studies of Ni(II), Cu(II) and Zn(II) complexes derived from heterocyclic schiff base

  2021cites this paper
• Synthesis and Characterization of New Schiff-bases as Methicillin Resistant Staphylococcus Aureus (MRSA) Inhibitors

  2021cites this paper
• Synthesis, structure, spectral, redox properties and anti-cancer activity of Ruthenium(II) Arene complexes with substituted Triazole Ligands

  2021cites this paper
• Opportunities for interfacing organometallic catalysts with cellular metabolism

  2021cites this paper
• Organometallic Chemistry of Anticancer Ruthenium and Osmium Complexes

  2021cites this paper
• Targeted Antibacterial Strategy Based on Reactive Oxygen Species Generated from Dioxygen Reduction Using an Organoruthenium Complex

  2021cites this paper
• Synthesis, characterization and crystal structures of half-sandwich ruthenium complexes with bidentate chiral Schiff-base ligands

  2020cites this paper
• Synthesis, protonation constants and biological activity determination of amino acid–salicylaldehyde-derived Schiff bases

  2020cites this paper
• Harnessing Endogenous Formate for Antibacterial Prodrug Activation via in cellulo Ruthenium-mediated Transfer Hydrogenation Reaction.

  2020cites this paper
• Crystal structure of chlorido-(η6-p-cymene)-(N-(2-fluorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) – acetone (1/1), C22H23ClN2F7OPRu

  2020cites this paper
• Ternary Co(II), Ni(II) and Cu(II) complexes containing dipyridophenazine and saccharin: Structures, reactivity, binding interactions with biomolecules and DNA damage activity

  2020cites this paper
• Variable structural bonding modes and antibacterial studies of thiosemicarbazone ligands of ruthenium, rhodium, and iridium metal complexes

  2020cites this paper
• Recent advances in anticancer ruthenium Schiff base complexes

  2020cites this paper
• Endoplasmic reticulum stress: an arising target for metal-based anticancer agents.

  2020cites this paper
• Exploring the In Vivo and In Vitro Anticancer Activity of Rhenium Isonitrile Complexes.

  2020cites this paper
• Synthesis, characterization, and antimicrobial studies of half-sandwich η6-toluene ruthenium complexes with N,N′-bidentate ligands

  2020cites this paper
• Comparative structural description of five arene ruthenium(II) complexes of N,N-bidentate Schiff base ligands to related complexes from literature

  2020cites this paper
• Synthesis of Amino Acid Schiff Base Nickel (II) Complexes as Potential Anticancer Drugs In Vitro

  2020cites this paper
• Chemotherapeutic Potential of Ruthenium Metal Complexes Incorporating Schiff Bases

  2020cites this paper
• Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

  2020cites this paper
• Metallodrugs are unique: opportunities and challenges of discovery and development

  2020cites this paper
• Synthesis, characterization and cytotoxic activity of cationic half-sandwich Ru(ii) complexes stabilized by iminophosphorane N,N,S and N,N,Se tridentate ligands

  2020cites this paper
• SYNTHESIS AND ANTITUMOR ACTIVITY OF NEW MULTIFUNCTIONAL COUMARINS

  2020influential citation
• DDDT_A_275007 5375..5392

  2020cites this paper
• Binuclear half-sandwich ruthenium(II) Schiff base complexes: Synthesis, characterization, DFT study and catalytic activity for the reduction of nitroarenes

  2019cites this paper
• Ruthenium arene complexes with mono-carbonyl analogues of curcumin as pendant or bridging ligands: Synthesis, anti-cancer activity and interaction with quadruplex DNA

  2019cites this paper
• Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium(ii)–arene-2-heteroarylbenzoxazole complexes

  2019cites this paper
• Half‐sandwich ruthenium‐based versatile catalyst for both alcohol oxidation and catalytic hydrogenation of carbonyl compounds in aqueous media

  2019cites this paper
• Half‒Sandwich (η6‒p‒Cymene) Ruthenium(II) complexes bearing 5‒Amino‒1‒Methyl‒3‒Phenylpyrazole Schiff base ligands: Synthesis, structure and catalytic transfer hydrogenation of ketones

  2019cites this paper
• Combinatorial Synthesis to Identify a Potent, Necrosis-Inducing Rhenium Anticancer Agent.

  2019cites this paper
• Induction of the Endoplasmic Reticulum Stress Pathway by Highly Cytotoxic Organoruthenium Schiff-Base Complexes.

  2018cites this paper
• Structural Determination of Ruthenium Complexes Containing Bi-Dentate Pyrrole-Ketone Ligands

  2018cites this paper
• Biological evaluation of new organoruthenium(II) metallates containing 3-acetyl-8-methoxy-2H-chromen-2-one appended CNS donor Schiff bases

  2018cites this paper
• New Ru(II) half sandwich complexes bearing the N,N′ bidentate 9-ethyl-N-(pyridin-2-ylmethylene)9H-carbazole-3-amine ligand: Effects of halogen (Cl−, Br− and I−) leaving groups versus in vitro activity on HepG2 cancer cells, cell cycle, fluorescence study, cellular accumulation and DFT study

  2018cites this paper
• Homogeneous polymetallic ruthenium(II)^zinc(II) complexes: robust catalysts for the efficient hydrogenation of levulinic acid to γ-valerolactone

  2018cites this paper
• An investigation on 3-acetyl-7-methoxy-coumarin Schiff bases and their Ru(ii) metallates with potent antiproliferative activity and enhanced LDH and NO release

  2018cites this paper
• Cyclometallated ruthenium(ii) complexes with 3-acetyl-2[H]-chromene-2-one derived CNS chelating ligand systems: synthesis, X-ray characterization and biological evaluation

  2018cites this paper
• Highly selective and efficient solvent-free transformation of bio-derived levulinic acid to γ-valerolactone by Ru(II) arene catalyst precursors

  2018cites this paper
• Synthesis, cytotoxicity and anti-metastatic properties of new pyridyl–thiazole arene ruthenium(II) complexes

  2018cites this paper
• Synthesis of α-Formylated N-Heterocycles and Their 1,1-Diacetates from Inactivated Cyclic Amines Involving an Oxidative Ring Contraction.

  2018cites this paper
• Antiproliferative, antioxidant, computational and electrochemical studies of new azo-containing Schiff base ruthenium(II) complexes

  2018cites this paper
• Oxidation of olefins catalyzed by half-sandwich osmium(II) arene complexes

  2018cites this paper
• Synthesis and characterization of water-soluble arene-ruthenium complexes and their application in biphasic olefin oxidation

  2018cites this paper
• Synthesis of six 8-quinolinate-based ruthenium complexes with high catalytic activity for nitroarene reduction

  2018cites this paper
• Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.

  2018cites this paper
• Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.

  2018cites this paper
• Crystal structure of (η6-1-isopropyl-4-methyl benzene)-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) perchlorate, C22H22Cl4N2O4Ru

  2018cites this paper
• Syntheses, characterization and catalytic activities of half-sandwich ruthenium complexes with naphthalene-based Schiff base ligands

  2017cites this paper
• Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors

  2017cites this paper
• The Interaction of a New Schiff Base Ligand with Human Serum Albumin: Molecular Docking and Molecular Dynamics Simulation Studies

  2017cites this paper
• Organoruthenium(II)-Arene Complexes: Structural Building Blocks for Anticancer Drug Discovery

  2017cites this paper
• Synthesis, Structure and Spectroscopic Characterization of Halfsandwich RuII Complexes containing 1,8‐Naphthalimide Ligands

  2017cites this paper